The Department of Health and Social Care (DH) has extended supply disruption alert issued for Fluoxetine 30mg capsules and Levothyroxine 12.5mcg tablets.
The serious shortage protocol (SSP) for Fluoxetine 30mg capsules was previously expected to expire on March 12 but the end date has been further extended until May 17.
Also, the SSP010 for Levothyroxine 12.5mcg tablets was previously expected to expire on March 12, but the end date has been further extended to March 19.
Product details
| SSP & Product | Current expiry date |
| SSP07: Fluoxetine 30mg capsules | This SSP has been varied – the revised end date for SSP07 is now 17th May 2021 |
| SSP010: Levothyroxine 12.5mcg tablets | This SSP has been varied – the revised end date for SSP010 is now 19th March 2021 |
Reimbursement will be made for the medicine supplied in accordance with the SSP and not the originally prescribed medicine.
The reimbursement price will account for VAT payment. Supply in accordance with the SSP will result in the following fees being paid to the contractor
One Single Activity fee (currently £1.27)
One SSP fee (£5.35)
